中国临床药理学杂志2025，Vol.41Issue(2)：174-177,4.DOI:10.13699/j.cnki.1001-6821.2025.02.005
氢化可的松联合连续性血液净化治疗脓毒症患者的临床研究
Clinical trial of hydrocortisone combined with continuous blood purification in the treatment of sepsis patients
摘要
Abstract
Objective To observe the clinical efficacy and safety of hydrocortisone injection combined with continuous blood purification in the treatment of sepsis patients.Methods Sepsis patients were randomly divided into control group and treatment group.The control group received continuous blood purification treatment;on the basis treatment of control group,the treatment group received hydrocortisone 200 mg,qd,intravenous infusion.Two groups were treated for 1 week.The clinical efficacy,levels of inflammatory cytokines,cellular immune function indicators,and safety were compared between two groups.Results Fifty-six cases were enrolled in the treatment group,5 cases were excluded,and ultimately 51 cases were included in the statistical analysis.Fifty-five cases were enrolled in the control group,4 cases were excluded,and ultimately 51 cases were included in the statistical analysis.After treatment,the total effective rates of the treatment and control groups were 94.12％(48 cases/51 cases)and 74.51％(38 cases/51 cases)with statistical significant difference(P＜0.05).After treatment,the levels of C-reactive protein in the treatment and control groups were(12.21±2.35)and(15.18±2.25)mg•L-1,the levels of procalcitonin were(0.49±0.13)and(0.78±0.21)ng•mL-1,the levels of CD3+were(58.72±5.13)％and(54.21±4.47)％,the CD4+/CD8+ratios were 1.71±0.23 and 1.43±0.17,respectively.The differences were statistically significant(all P＜0.05).The adverse drug reactions of treatment group were chest tightness,nausea,and vomiting,while those in the control group were hypotension,nausea,and vomiting.The total incidences of adverse drug reactions in the treatment and control groups were 9.80％and 5.88％,without significant difference(P＞0.05).Conclusion Hydrocortisone injection combined with continuous blood purification have a definitive clinical efficacy in the sepsis patients,which can improve the patients'immune function,reduce inflammatory reactions,without increasing the incidences of adverse drug reactions.关键词
氢化可的松注射剂/连续性血液净化/脓毒症/炎症反应/细胞免疫功能/安全性评价Key words
hydrocortisone injection/continuous blood purification/sepsis/inflammatory response/cellular immune function/safety evaluation分类
医药卫生引用本文复制引用
李锋,朱陈强,王刚,张喆..氢化可的松联合连续性血液净化治疗脓毒症患者的临床研究[J].中国临床药理学杂志,2025,41(2):174-177,4.基金项目
浙江省医药卫生科技计划基金资助项目(2024XY128) （2024XY128）
